肾脏病患者COVID-19的预防与早期门诊治疗:欧洲肾脏协会免疫肾脏病工作组(ERA-IWG)的考量
欧洲肾脏协会免疫肾脏病工作组(ERA-IWG)发布专家意见,总结免疫介导性肾脏病、慢性肾脏病和肾移植受者中SARS-CoV-2感染的预防性和早期治疗选择(中和性单克隆抗体和直接抗病毒药物)。该类患者即使接种三剂以上疫苗仍呈高无应答率,且接受某些免疫抑制剂时病毒清除能力降低, COVID-19相关发病和死亡风险升高。
要点
- 免疫介导性肾脏病、慢性肾脏病和肾移植受者对疫苗接种高无应答,感染后病毒清除能力降低。
- SARS-CoV-2变异和刺突突变导致中和抗体效力减弱。
- 治疗策略从疫苗接种扩展至免疫接种、暴露前预防和早期暴露后治疗(直接抗病毒药物和中和性单克隆抗体)联合方案。
核心结论
- 本专家意见总结了免疫介导性肾脏病、慢性肾脏病和肾移植受者中SARS-CoV-2感染的预防性和/或早期治疗选择(中和性单克隆抗体和直接抗病毒药物)。
研究设计与样本
- 欧洲肾脏协会免疫肾脏病工作组(ERA-IWG)的专家意见论文。
主要发现
- 免疫介导性肾脏病、慢性肾脏病和肾移植受者尽管接种三剂以上疫苗仍呈高无应答率。
- 接受某些免疫抑制剂的患者感染后病毒清除能力降低,COVID-19相关发病和死亡风险升高。
- SARS-CoV-2进化出现新变异和刺突突变,导致中和抗体效力减弱。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic led to rapid vaccine development and large global vaccination schemes. However, patients with immune-mediated kidney disease, chronic kidney diseases and kidney transplant recipients show high non-response rates to vaccination despite more than three vaccinations and, consequently, reduced viral clearance capacity when infected while receiving certain immunosuppressants, carrying an elevated risk for coronavirus disease 2019 (COVID-19)-related morbidity and mortality. SARS-CoV-2 evolution has been characterized by the emergence of novel variants and spike mutations contributing to waning efficacy of neutralizing antibodies. To this end, the therapeutic field expands from vaccination towards a combined approach of immunization, pre-exposure prophylaxis and early post-exposure treatment using direct-acting antivirals and neutralizing monoclonal antibodies to treat early in the disease course and avoid hospitalization. This expert opinion paper from the Immunonephrology Working Group of the European Renal Association (ERA-IWG) summarizes available prophylactic and/or early treatment options (i.e. neutralizing monoclonal antibodies and direct-acting antivirals) of SARS-CoV-2-infected patients with immune-mediated kidney disease, chronic kidney disease and kidney transplant recipients.
引用
- Hilhorst M, Bemelman FJ, Bruchfeld A, et al. Prophylactic and early outpatient treatment of COVID-19 in patients with kidney disease: considerations from the Immunonephrology Working Group of the European Renal Association (ERA-IWG). Nephrol Dial Transplant. 2023. PMID: 36881727. doi:10.1093/ndt/gfad044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。